Curcuma longa Extract Improves Knee Pain in Osteoarthritis
TUESDAY, Sept. 15, 2020 -- For patients with knee osteoarthritis, Curcuma longa extract (CL) is more effective than placebo for knee pain but does not improve knee effusion-synovitis, according to a study published online Sept. 15 in the Annals of Internal Medicine.
Zhiqiang Wang, M.Pharm., from the University of Tasmania in Australia, and colleagues examined the efficacy of CL for reducing knee symptoms and effusion-synovitis in patients with knee osteoarthritis. Seventy patients were randomly assigned to either two capsules of CL (36 patients) or matched placebo (34 patients) daily for 12 weeks.
The researchers found that compared with placebo, CL improved pain on a visual analog scale by −9.1 mm, while there was no change in effusion-synovitis volume. In addition, there was improvement in the Western Ontario and McMaster Universities Osteoarthritis Index knee pain (−47.2 mm) but no improvement in lateral femoral cartilage T2 relaxation time. The incidence of adverse events was similar in the CL and placebo groups (39 and 53 percent, respectively); two and five events in the CL and placebo groups, respectively, may have been related to treatment.
"CL improved knee pain versus placebo in patients with knee osteoarthritis with local inflammation over 12 weeks, with no increase in adverse events," the authors write. "The effect on pain was only moderate; however, it was achieved without any effect on knee structural measures assessed by magnetic resonance imaging."
Several authors disclosed financial ties to the pharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted September 2020
Read this next
WEDNESDAY, June 16, 2021 -- Nonsurgical osteoarthritis care is associated with lower rates of total knee arthroplasty (TKA) among elderly Americans with knee osteoarthritis...
WEDNESDAY, June 9, 2021 -- Osteoarthritis (OA) may be associated with the risk for developing Parkinson disease (PD), especially among patients with knee or hip OA, according to a...
TUESDAY, June 1, 2021 -- For patients undergoing surgical treatment for end-stage ankle arthritis, those undergoing total ankle arthroplasty (TAA) and ankle arthrodesis (AA) have...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.